Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension

Clinical Therapeutics

Volumn 35, Issue 9, 2013, Pages 1423-1430

  Matthews, Kathleen A ^a   Brenner, Michael J ^a   Brenner, Allison C ^a  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Blood pressure; Chlorthalidone; Drug toxicity; Hydrochlorothiazide; Hypertension; Veterans Affairs

Indexed keywords

CALCIUM; CHLORTALIDONE; CREATININE; ELECTROLYTE; HYDROCHLOROTHIAZIDE; POTASSIUM; SODIUM;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROLYTE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; POTASSIUM BLOOD LEVEL; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; VETERAN;

BLOOD PRESSURE; CHLORTHALIDONE; DRUG TOXICITY; HYDROCHLOROTHIAZIDE; HYPERTENSION; VETERANS AFFAIRS;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CALCIUM; CHLORTHALIDONE; CREATININE; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES; VETERANS;

EID: 84884349778     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2013.07.430     Document Type: Article

References (17)

1. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program. Bethesda, Md: National Heart, Lung, and Blood Institute (US); 2004. NIH Publication No. 04-5230.
2. VHA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension in the Primary Care Setting. Washington, DC: Office of Quality and Performance and the Veterans Affairs and Department of Defense Development Work Group, Veterans Health Administration, Department of Veterans Affairs; 1999. Update 2004.
3. Barthlow M. Top 200 Drugs of 2010. Pharmacy Times. Accessed September 5, 2011. http://www.pharmacytimes.com/publications/issue/2011/May2011/Top-200-Drugs-of-2010.
4. Ernst M.E., Lund B.C. Renewed interest in chlorthalidone: evidence from the Veteran's Health Administration. J Clin Hypertens 2010, 12:927-934.
5. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981-2997. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.
6. Mortality rates after 10.5 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation 1990, 82:1616-1628. The Multiple Risk Factor Intervention Trial Research Group (MRFIT).
7. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991, 265:3255-3264. SHEP Cooperative Research Group.
8. Five-year findings of the hypertension detection and follow-up program I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979, 242:2562-2571. Hypertension Detection and Follow-up Program Cooperative Group.
9. Neaton J.D., Grimm R.H., Prineas R.J., et al. Treatment of mild hypertension study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA 1993, 270:713-724. for the Treatment of Mild Hypertension Study Research Group.
10. Ernst M.E., Carter B.L., Goerdt C.J., et al. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006, 47:352-358.
11. Dorsch M.P., Gillespie B.W., Erickson S.R., et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 2011, 57:689-694.
12. Ernst M.E., Neaton J.D., Grimm R.H., et al. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the Multiple Risk Factor Intervention trial. Hypertension 2011, 58:1001-1007.
13. Khosla N., Chua D.Y., Elliott W.J., Bakris G.L. Are chlorthalidone and hydrochlorothiazide equivalent blood pressure-lowering medications?. J Clin Hypertens 2005, 7:354-356.
14. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979, 6:65-70.
15. Calhoun D.A., Jones D., Textor S., et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008, 51:1403-1419.
16. Benner J.S., Chapman R.H., Petrilla A.A., et al. Association between prescription burden and medication adherence in antihypertensive and lipid-lowering therapy. Am J Health-Syst Pharm 2009, 66:1471-1477.
17. Chapman R.H., Petrilla A.A., Benner J.S., et al. Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study. Drugs Aging 2008, 25:885-892.